BPC
AGN

Banque Pictet & Cie’s Allergan plc AGN Stock Holding History

Banque Pictet & Cie’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-20,885
Closed -$3.7M – 355
2020
Q1 		$3.7M Sell
20,885
-4,571
-18% -$861K 0.08% 140
2019
Q4 		$4.87M Buy
+25,456
New +$4.59M 0.08% 151
2015
Q1 		– Sell
-5,547
Closed -$1.43M – 507
2014
Q4 		$1.43M Buy
+5,547
New +$1.39M 0.04% 220

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Banque Pictet & Cie's AGN Position: Q2 2020 in Review

Banque Pictet & Cie sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 20,885 shares — an estimated $3.7M sold.

Banque Pictet & Cie first reported a position in AGN in Q4 2014 and held it in 3 quarters. The position peaked at $4.87M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Banque Pictet & Cie reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Banque Pictet & Cie sold 20,885 Allergan plc shares in Q2 2020, an estimated $3.7M.
  • Banque Pictet & Cie first reported a position in Allergan plc in Q4 2014 and held it in 3 quarters.
  • Banque Pictet & Cie's Allergan plc position peaked at $4.87M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Banque Pictet & Cie's 13F filing for Q2 2020, filed 13 Aug 2020.